Skip to content
Search

Latest Stories

Britain set to isolate over-70s as coronavirus deaths rise to 35

Britain will isolate older people "within weeks" and force into quarantine anyone diagnosed with coronavirus, the government said as it stepped up measures that have so far been less stringent than elsewhere in Europe.

Heath Secretary Matt Hancock said people aged over 70 would be shielded from the virus by self-isolating for up to four months, with an announcement "in the coming weeks".


Department of Health and Social Care has on Friday launched a new guidance for adult social care to ensure older people and those with pre-existing conditions and care needs who receive support are best protected against the virus.

Britain has taken a distinctly different approach to tackling coronavirus from European countries such as Italy, Spain and France which have imposed stringent lockdowns to try to slow the spread of the disease.

The number of deaths of Britons with coronavirus jumped by 14 in the last 24 hours to 35, while the total diagnosed rose by 20 per cent to 1,372, health authorities said on Sunday.

Hancock said the rise in Britain had been slower than in other parts of Europe, in part due to measures taken by authorities to trace people who had contact with those affected.

The government said last week that in terms of the scale of the outbreak Britain was four weeks behind Italy, where 1,809 have died and 24,747 have been diagnosed.

He said isolating old people was in Britain's action plan, but it was a "very big ask" and people could tire of complying.

"We will be setting it out with more detail when it's the right time to do so because we absolutely appreciate that that is a very big ask of the elderly and the vulnerable and it's for their own self-protection," he told Sky News on Sunday.

The government will legislate this week to force people into quarantine if they are diagnosed with the virus, he said, and was also ready to ban mass gatherings.

"We are going to take the powers to make sure that we can quarantine people if they are a risk to public health," Hancock said. "I doubt we will need to use it much because people are being very responsible and people need to be responsible."

Britain is aiming to delay the peak of infection to prevent health services from being overwhelmed when they are less able to cope.

Hancock said Britain's approach was underpinned by scientific evidence, which it would publish in the coming days, and it was aimed solely at protecting life.

"We will stop at nothing to fight this virus and I think people have got the impression otherwise," he told the BBC.

The concept of herd immunity - where the virus spreads through the population to increase overall resistance - was not part of the government's strategy, he added.

Britain has called for a national effort to tackle coronavirus similar to the one which helped it survive the Second World War

"Our generation has never been tested like this," Hancock wrote in the Sunday Telegraph. "Our grandparents were, during the Second World War, when our cities were bombed during the Blitz.

"Today our generation is facing its own test, fighting a very real and new disease. We must fight the disease to protect life."

The government is asking manufacturers to retool production lines to start producing more ventilators, and could turn some hotels into hospitals to take coronavirus patients who cannot be treated in overstretched public hospitals.

More For You

AAH Pharmaceuticals introduces 20 new electric vans to its delivery fleet

18 vans have been added to the AAH DC in Ruislip, and another 2 to their branch in Glasgow

Photo credit: AAH

AAH Pharmaceuticals adds 20 new electric vans to reduce carbon emissions

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced 20 new electric vans to its delivery fleet, marking a significant step forward in its Carbon Reduction Plan, which is aligned to the NHS net zero targets.

Eighteen of the new electric vehicles have been deployed at the AAH distribution centre in Ruislip, with the remaining two now in operation at its Glasgow branch.

Keep ReadingShow less
Numark launches new digital consultation platform to support independent prescribers

Harry McQuillan, Chairman of Numark

Numark launches DigiPharma to empower independent prescribers

Numark has launched a new digital consultation platform, called DigiPharma, designed to support both current and future independent prescribers (IPs) in making full use of their qualifications.

The revolutionary cloud-based prescribing recording platform is now available exclusively to Numark members.

Keep ReadingShow less
Operation Subaru:

Some of the medicines seized in raids today. Credit: MHRA

12 arrested in MHRA’s biggest medicines trafficking crackdown

Twelve people have been arrested in a series of dawn raids across the West Midlands and the Northwest of England today (29 April), as part of the biggest criminal investigation ever undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA) into organised medicines trafficking.

The suspects were detained on suspicion of involvement in organised crime, conspiracy to sell or supply controlled and unlicensed medicines, and money laundering.

Keep ReadingShow less
Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less